Participant flow

Cisplatin, Fluorouracil, Iressa, and Radiation Therapy Patients With Locally Advanced Head and Neck Cancer · Source last updated 2012-11-05

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

groups

1. description

   Patients undergo hyperfractionated radiotherapy twice daily, 5 days a week, beginning on day 1 and continuing for 6 weeks. Patients also receive fluorouracil IN continuously over 96 hrs. and cisplatin IV continuously over 96 hrs. on days 1-3 and 22-25 and oral gefitinib beginning once daily on day 1 and continuing for up to 2 years in the absence of disease progression or unacceptable toxicity.

   id

   FG000

   title

   5-FU, Cisplatin, Radiation and Iressa

periods

1. drop Withdraws

   1. reasons

      1. group Id

         FG000

         num Subjects

         5

      type

      Death

   2. reasons

      1. group Id

         FG000

         num Subjects

         5

      type

      Withdrawal by Subject

   3. reasons

      1. group Id

         FG000

         num Subjects

         9

      type

      Lack of Efficacy

   4. reasons

      1. group Id

         FG000

         num Subjects

         19

      type

      Adverse Event

   5. reasons

      1. group Id

         FG000

         num Subjects

         2

      type

      Protocol Violation

   milestones

   1. achievements

      1. group Id

         FG000

         num Subjects

         60

      type

      STARTED

   2. achievements

      1. group Id

         FG000

         num Subjects

         20

      type

      COMPLETED

   3. achievements

      1. group Id

         FG000

         num Subjects

         40

      type

      NOT COMPLETED

   title

   Overall Study

recruitment Details

Patients accrued between April 2003 and December 2007 from clinical facility

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice